|
rs1050501 |
SNP |
PedAM |
snpId=rs1050501; pubmedId=12486608; geneId=2213; geneSymbol=FCGR2B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=This study was performed to examine whether FCGR2B-I232T was associated with susceptibility to rheumatoid arthritis in the Japanese.; score=0.006448592; Year=2002; geneSymbol_dbSNP=FCGR2B; CHROMOSOME=1; POS=161674008; REF=T; ALT=C |
details
|
|
|
rs1051266 |
SNP |
PedAM |
snpId=rs1051266; pubmedId=15564880; geneId=8836; geneSymbol=GGH; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated whether polymorphisms in reduced folate carrier (SLC19A1 G80A) and gamma-glutamyl-hydrolase (GGH-401C/T) are predictive of methotrexate polyglutamate (MTXPG) levels in patients with rheumatoid arthritis treated with weekly low-dose methotrexate (MTX).; score=0.130011012; Year=2004; geneSymbol_dbSNP=SLC19A1; CHROMOSOME=21; POS=45537880; REF=T; ALT=C |
details
|
|
|
rs1051266 |
SNP |
PedAM |
snpId=rs1051266; pubmedId=17965559; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Frequencies of MTHFR C677T and A1298C were similar to those reported in Japanese RA patients, while frequencies of RFC-1 G80A genotypes differed from those reported in RA patients in the United States.; score=0.019998279; Year=2007; geneSymbol_dbSNP=SLC19A1; CHROMOSOME=21; POS=45537880; REF=T; ALT=C |
details
|
|
|
rs1051266 |
SNP |
PedAM |
snpId=rs1051266; pubmedId=15457444; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated the contribution of common genetic polymorphisms in RFC-1 (G80A), ATIC (C347G), and TS (28-bp tandem repeats located in the TS enhancer region [TSER*2/*3]) and of MTXPGs to the effect of MTX in patients with rheumatoid arthritis.; score=0.019998279; Year=2004; geneSymbol_dbSNP=SLC19A1; CHROMOSOME=21; POS=45537880; REF=T; ALT=C |
details
|
|
|
rs1051266 |
SNP |
PedAM |
snpId=rs1051266; pubmedId=15457444; geneId=471; geneSymbol=ATIC; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated the contribution of common genetic polymorphisms in RFC-1 (G80A), ATIC (C347G), and TS (28-bp tandem repeats located in the TS enhancer region [TSER*2/*3]) and of MTXPGs to the effect of MTX in patients with rheumatoid arthritis.; score=0.137197984; Year=2004; geneSymbol_dbSNP=SLC19A1; CHROMOSOME=21; POS=45537880; REF=T; ALT=C |
details
|
|
|
rs1051266 |
SNP |
PedAM |
snpId=rs1051266; pubmedId=24350725; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The aim of our study was to characterize the association of clinicopathological variables and the SLC19A1/RFC-1 G80A polymorphism in methotrexate (MTX)-related toxicity in Portuguese patients with rheumatoid arthritis.; score=0.019998279; Year=2015; geneSymbol_dbSNP=SLC19A1; CHROMOSOME=21; POS=45537880; REF=T; ALT=C |
details
|
|
|
rs1051266 |
SNP |
PedAM |
snpId=rs1051266; pubmedId=15564880; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated whether polymorphisms in reduced folate carrier (SLC19A1 G80A) and gamma-glutamyl-hydrolase (GGH-401C/T) are predictive of methotrexate polyglutamate (MTXPG) levels in patients with rheumatoid arthritis treated with weekly low-dose methotrexate (MTX).; score=0.019998279; Year=2004; geneSymbol_dbSNP=SLC19A1; CHROMOSOME=21; POS=45537880; REF=T; ALT=C |
details
|
|
|
rs1051266 |
SNP |
PedAM |
snpId=rs1051266; pubmedId=22971639; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The results of this study suggest that the RFC1 G80A polymorphism may be a useful marker for predicting MTX efficacy in Japanese patients with RA.; score=0.019998279; Year=2014; geneSymbol_dbSNP=SLC19A1; CHROMOSOME=21; POS=45537880; REF=T; ALT=C |
details
|
|
|
rs1051792 |
SNP |
PedAM |
snpId=rs1051792; pubmedId=21702010; geneId=100507436; geneSymbol=MICA; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Japanese patients with SLE (n=716), those with rheumatoid arthritis (RA) (n=327), and healthy control subjects (n=351) were genotyped for the Val129 Met polymorphism (rs1051792) and transmembrane (TM) alanine-encoding GCT repeats, termed A4, A5, A5.1, A6, and A9, in the MICA gene.; score=0.003995683; Year=2011; geneSymbol_dbSNP=MICA; CHROMOSOME=6; POS=31411200; REF=G; ALT=A |
details
|
|
|
rs1051792 |
SNP |
PedAM |
snpId=rs1051792; pubmedId=21702010; geneId=25797; geneSymbol=QPCT; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Japanese patients with SLE (n=716), those with rheumatoid arthritis (RA) (n=327), and healthy control subjects (n=351) were genotyped for the Val129 Met polymorphism (rs1051792) and transmembrane (TM) alanine-encoding GCT repeats, termed A4, A5, A5.1, A6, and A9, in the MICA gene.; score=0.000271442; Year=2011; geneSymbol_dbSNP=MICA; CHROMOSOME=6; POS=31411200; REF=G; ALT=A |
details
|
|
|
rs1061622 |
SNP |
PedAM |
snpId=rs1061622; pubmedId=18565259; geneId=7133; geneSymbol=TNFRSF1B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.; score=0.073283014; Year=2008; geneSymbol_dbSNP=TNFRSF1B; CHROMOSOME=1; POS=12192898; REF=T; ALT=G |
details
|
|
|
rs1061622 |
SNP |
PedAM |
snpId=rs1061622; pubmedId=16871413; geneId=7133; geneSymbol=TNFRSF1B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features.; score=0.073283014; Year=2006; geneSymbol_dbSNP=TNFRSF1B; CHROMOSOME=1; POS=12192898; REF=T; ALT=G |
details
|
|
|
rs1061622 |
SNP |
PedAM |
snpId=rs1061622; pubmedId=24777778; geneId=7133; geneSymbol=TNFRSF1B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.; score=0.073283014; Year=2014; geneSymbol_dbSNP=TNFRSF1B; CHROMOSOME=1; POS=12192898; REF=T; ALT=G |
details
|
|
|
rs1061622 |
SNP |
PedAM |
snpId=rs1061622; pubmedId=18565259; geneId=2214; geneSymbol=FCGR3A; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.; score=0.062385613; Year=2008; geneSymbol_dbSNP=TNFRSF1B; CHROMOSOME=1; POS=12192898; REF=T; ALT=G |
details
|
|
|
rs10760130 |
SNP |
PedAM |
snpId=rs10760130; pubmedId=20498205; geneId=1493; geneSymbol=CTLA4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.345272224; Year=2010; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120939712; REF=G; ALT=A |
details
|
|
|
rs10760130 |
SNP |
PedAM |
snpId=rs10760130; pubmedId=20498205; geneId=7185; geneSymbol=TRAF1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.311201237; Year=2010; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120939712; REF=G; ALT=A |
details
|
|
|
rs10760130 |
SNP |
PedAM |
snpId=rs10760130; pubmedId=20498205; geneId=958; geneSymbol=CD40; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.277186332; Year=2010; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120939712; REF=G; ALT=A |
details
|
|
|
rs10760130 |
SNP |
PedAM |
snpId=rs10760130; pubmedId=20498205; geneId=6775; geneSymbol=STAT4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.316739695; Year=2010; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120939712; REF=G; ALT=A |
details
|
|
|
rs10760130 |
SNP |
PedAM |
snpId=rs10760130; pubmedId=20498205; geneId=26191; geneSymbol=PTPN22; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.524345611; Year=2010; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120939712; REF=G; ALT=A |
details
|
|
|
rs10760130 |
SNP |
PedAM |
snpId=rs10760130; pubmedId=20498205; geneId=3798; geneSymbol=KIF5A; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Eight markers (ie, rs1160542 (AFF3), rs1678542 (KIF5A), rs2476601 (PTPN22), rs3087243 (CTLA4), rs4810485 (CD40), rs5029937 (6q23), rs10760130 (TRAF1/C5) and rs7574865 (STAT4)) were significantly associated with RA by meta-analysis.; score=0.254473634; Year=2010; geneSymbol_dbSNP=NA; CHROMOSOME=9; POS=120939712; REF=G; ALT=A |
details
|
|
